Literature DB >> 2550807

Antibodies to synthetic peptide from the residue 33 to 42 domain of c-Ha-ras p21 block reconstitution of the protein with different effectors.

I Rey1, P Soubigou, L Debussche, C David, A Morgat, P E Bost, J F Mayaux, B Tocque.   

Abstract

Residues 32 to 40, which are conserved among ras proteins from different species, are likely to participate in interactions with the p21 effector system. With the goal of understanding the structural basis of the regulatory functions of c-Ha-ras p21, we produced rabbit antisera against a synthetic peptide corresponding to amino acids 33 to 42 of the protein. The affinity-purified antibodies interacted specifically with p21 and with the antigenic peptide. The epitope recognized by the antibodies appeared to be centered on threonine 35. The antibodies inhibited both in vitro p21-induced production of cyclic AMP in detergent extracts of RAS-defective yeast membranes and GAP-stimulated GTPase activity. However, monoclonal anti-ras antibodies Y13-259 and Y13-238 were not capable of specifically inhibiting interactions of p21 with these two putative effector proteins. The apparent inhibitory effect of Y13-259 on stimulation of p21 by GAP was due to a greatly reduced rate of exchange of nucleotides in the binding pocket of the protein. These findings provide additional support for the essential role of the residue 32 to 40 domain as the true effector site and further evidence of the involvement of GAP as a cellular effector of ras proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550807      PMCID: PMC362452          DOI: 10.1128/mcb.9.9.3904-3910.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody.

Authors:  S Hattori; L S Ulsh; K Halliday; T Y Shih
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

3.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

4.  Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins.

Authors:  H F Kung; M R Smith; E Bekesi; V Manne; D W Stacey
Journal:  Exp Cell Res       Date:  1986-02       Impact factor: 3.905

5.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Functional homology of mammalian and yeast RAS genes.

Authors:  T Kataoka; S Powers; S Cameron; O Fasano; M Goldfarb; J Broach; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

8.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Mammalian and yeast ras gene products: biological function in their heterologous systems.

Authors:  D DeFeo-Jones; K Tatchell; L C Robinson; I S Sigal; W C Vass; D R Lowy; E M Scolnick
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  5 in total

1.  Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain.

Authors:  V Leblanc; B Tocque; I Delumeau
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

2.  The Saccharomyces cerevisiae SDC25 C-domain gene product overcomes the dominant inhibitory activity of Ha-Ras Asn-17.

Authors:  F Schweighoffer; H Cai; M C Chevallier-Multon; I Fath; G Cooper; B Tocque
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

3.  Complex formation between RAS and RAF and other protein kinases.

Authors:  L Van Aelst; M Barr; S Marcus; A Polverino; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation.

Authors:  M Pomerance; M N Thang; B Tocque; M Pierre
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

5.  Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum Sensing.

Authors:  Maria López; Lucia Blasco; Eva Gato; Astrid Perez; Laura Fernández-Garcia; Luis Martínez-Martinez; Felipe Fernández-Cuenca; Jesús Rodríguez-Baño; Alvaro Pascual; German Bou; Maria Tomás
Journal:  Front Cell Infect Microbiol       Date:  2017-05-09       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.